1. Market Research
  2. > Healthcare Market Trends
  3. > SCIO Health Analytics - Strategic SWOT Analysis Review

SCIO Health Analytics - Strategic SWOT Analysis Review

  • February 2016
  • -
  • Global Data
  • -
  • 23 pages

SCIO Health Analytics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

SCIO Health Analytics (SCIO Health) is a provider of analytics-based health care cost-containment solutions. Its solutions include revenue recovery, care management, data analytics, and business process optimization services for health care payors and self-insured employers. It provides actionable and predictive analytics, business services and insights in the areas of care and risk management, payment integrity, value-based benefit design, ACO analytics, consumer engagement, and network analytics to improve healthcare services and results. The company offers its services to health care organizations, pharmacy benefit management companies and life science organizations. It has delivery centers in the US, the UK, and India. SCIO Health is headquartered in West Hartford, Connecticut, the US.

SCIO Health Analytics Key Recent Developments

Oct 26, 2015: New Study Shows Wearable Ventilation Technology Significantly Improved Outcomes in Patients with Moderate to Severe Respiratory Disease

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

SCIO Health Analytics - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 3
Section 1 - About the Company 4
SCIO Health Analytics - Key Facts 4
SCIO Health Analytics - Key Employees 5
SCIO Health Analytics - Key Employee Biographies 6
SCIO Health Analytics - Major Products and Services 7
SCIO Health Analytics - History 9
SCIO Health Analytics - Locations And Subsidiaries 12
Head Office 12
Other Locations and Subsidiaries 12
Section 2 - Company Analysis 14
SCIO Health Analytics - Business Description 14
SCIO Health Analytics - SWOT Analysis 16
SWOT Analysis - Overview 16
SCIO Health Analytics - Strengths 16
Strength - Comprehensive Cost-Containment Solutions 16
Strength - Large Customer Base 16
Strength - Proprietary Technologies 16
SCIO Health Analytics - Weaknesses 17
Weakness - Dependence on US Market 17
SCIO Health Analytics - Opportunities 18
Opportunity - Growth of Pharmaceutical Market 18
Opportunity - Inorganic Growth Initiatives 18
SCIO Health Analytics - Threats 19
Threat - Competitive Pressure 19
Threat - Rapid Changes in Technology 19
Threat - Stringent Government Regulations 19
SCIO Health Analytics - Key Competitors 20
SCIO Health Analytics, Recent Deals Summary 21
Section 3 - Company's Recent Developments 22
Oct 26, 2015: New Study Shows Wearable Ventilation Technology Significantly Improved Outcomes in Patients with Moderate to Severe Respiratory Disease 22
Section 4 - Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
SCIO Health Analytics, Key Facts 4
SCIO Health Analytics, Key Employees 5
SCIO Health Analytics, Key Employee Biographies 6
SCIO Health Analytics, Major Products and Services 7
SCIO Health Analytics, History 9
SCIO Health Analytics, Other Locations 12
SCIO Health Analytics, Subsidiaries 13
SCIO Health Analytics, Key Competitors 20
SCIO Health Analytics, Recent Deals Summary 21

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
3D Cell Culture Technologies Patent Landscape

3D Cell Culture Technologies Patent Landscape

  • $ 5489
  • Company report
  • September 2016
  • by KnowMade

IP landscape for 3D cell culture technologies offers an important space to big entities as well as for small companies 3D CELL CULTURE : REPRODUCING AN IN VIVO-LIKE ENVIRONMENT IN VITRO The patent landscape ...

Diabetes & Obesity Drug Development Pipeline Review, 2016

Diabetes & Obesity Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Diabetes & Obesity Drug Development Pipeline Review, 2016 Summary The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type ...

Ophthalmology Drug Development Pipeline Review, 2016

Ophthalmology Drug Development Pipeline Review, 2016

  • $ 3995
  • Company report
  • December 2016
  • by GBI Research

Ophthalmology Drug Development Pipeline Review, 2016 Summary Ophthalmology disorders are associated with the eyes and visual system. If left untreated, serious long-term co-morbidities such as diabetes, ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.